TRAVATAN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug TRAVATAN contains one active pharmaceutical ingredient (API):

1 Travoprost UNII WJ68R08KX9 - TRAVOPROST

Travoprost, a prostaglandin F2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways. Read about Travoprost

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRAVATAN Eye drops, solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EE04	Travoprost	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5554H, 8597L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500903801177316, 500912110006403
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01466172, 01466189, 16820509
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 363231112
Country: EE	Ravimiamet	Identifier(s): 1097041, 1130454
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 01199001, 01199001IP
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 517180, 581969
Country: FR	Base de données publique des médicaments	Identifier(s): 60670806
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 140104, 182026, 26702, 375935, 377075
Country: HK	Department of Health Drug Office	Identifier(s): 52367
Country: IE	Health Products Regulatory Authority	Identifier(s): 54231, 78605, 78621, 78634, 78642
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4598
Country: IT	Agenzia del Farmaco	Identifier(s): 035409010
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003997, 1009818, 1076196, 1080801
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 163M2001
Country: NL	Z-Index G-Standaard	Identifier(s): 14771934
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 61093
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 19306
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100108480
Country: SG	Health Sciences Authority	Identifier(s): 11817P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 1903051, 20833031
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504612127
Country: US	FDA, National Drug Code	Identifier(s): 0065-0260, 0078-0946
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/15.4/0333